Big-money moves in the US on 23/01/25 (Wed)

Insider buys: 77 trades
Insider sales: 235 trades
Congress trades: 0 trades

Notable trades of the day

No trade stood out on this day.

Trades disclosed this day

George Michel Doumet10% Owner
BuyUnited States Lime & Minerals
Buy
United States Lime & Minerals
USLM
$3M
24,137 sh
$3M
Filed 23/01/25
Traded 21/12/10
Inberdon Enterprises10% Owner
BuyUnited States Lime & Minerals
Buy
United States Lime & Minerals
USLM
$3M
24,137 sh
$3M
Filed 23/01/25
Traded 21/12/10
Inberdon Enterprises10% Owner
BuyUnited States Lime & Minerals
Buy
United States Lime & Minerals
USLM
$2.2M
17,500 sh
$2.2M
Filed 23/01/25
Traded 21/11/29
George Michel Doumet10% Owner
BuyUnited States Lime & Minerals
Buy
United States Lime & Minerals
USLM
$2.2M
17,500 sh
$2.2M
Filed 23/01/25
Traded 21/11/29
George Michel Doumet10% Owner
BuyUnited States Lime & Minerals
Buy
United States Lime & Minerals
USLM
$1.5M
10,729 sh
$1.5M
Filed 23/01/25
Traded 21/02/22
Inberdon Enterprises10% Owner
BuyUnited States Lime & Minerals
Buy
United States Lime & Minerals
USLM
$1.5M
10,729 sh
$1.5M
Filed 23/01/25
Traded 21/02/22
TCG Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group IV10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
TCG IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group Iii-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group IV-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group Opportunity III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Ponoi Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Ponoi II Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Peter Svennilson10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Tim Kutzkey10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group II GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column Group Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Ponoi Capital II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Ponoi Capital10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Douglas R. LebdaChairman & CEO
BuyLendingTree
Buy
LendingTree
TREE
$1.3M
40,043 sh
$1.3M
Filed 23/01/25
Traded 23/01/23
Douglas R. LebdaChairman & CEO
BuyLendingTree
Buy
LendingTree
TREE
$790.9K
25,019 sh
$790.9K
Filed 23/01/25
Traded 23/01/23
Zackary S. IraniCEO
BuyBiomerica
Buy
Biomerica
BMRA
$5,620
2,000 sh
$5,620
Filed 23/01/25
Traded 23/01/24
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
David V. GoeddelDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$49.5K
9,900 sh
$49.5K
Filed 23/01/25
Traded 23/01/23
John GrdinaPresident and CEO
BuyAdamas One
Buy
Adamas One
JEWL
$106.8K
40,000 sh
$106.8K
Filed 23/01/25
Traded 23/01/23
Wes CumminsCEO; Chairman
BuyApplied Digital
Buy
Applied Digital
APLD
$61.3K
25,000 sh
$61.3K
Filed 23/01/25
Traded 23/01/24
Michael D. PeduzziPresident & CEO
BuyCNB Financial
Buy
CNB Financial
CCNE
$32K
1,372 sh
$32K
Filed 23/01/25
Traded 23/01/25
Horizon Kinetics Asset Management10% Owner
BuyTexas Pacific Land
Buy
Texas Pacific Land
TPL
$24.8K
12 sh
$24.8K
Filed 23/01/25
Traded 23/01/24
Trian Fund Management10% Owner
SellInvesco
Sell
Invesco
IVZ
$72M
3,786,854 sh
$72M
Filed 23/01/25
Traded 23/01/23
Jeffrey E. EberweinCEO
BuyStar Equity Holdings
Buy
Star Equity Holdings
STRR
$15K
593 sh
$15K
Filed 23/01/25
Traded 23/01/24
Jeffrey E. EberweinCEO
BuyStar Equity Holdings
Buy
Star Equity Holdings
STRR
$14.4K
571 sh
$14.4K
Filed 23/01/25
Traded 23/01/25
Trian Fund Management10% Owner
SellInvesco
Sell
Invesco
IVZ
$43M
2,374,019 sh
$43M
Filed 23/01/25
Traded 23/01/25
Jeffrey E. EberweinCEO
BuyStar Equity Holdings
Buy
Star Equity Holdings
STRR
$13.1K
510 sh
$13.1K
Filed 23/01/25
Traded 23/01/23
Vito S. PantilionePresident & CEO
BuyParke Bancorp
Buy
Parke Bancorp
PKBK
$12.5K
600 sh
$12.5K
Filed 23/01/25
Traded 23/01/23
John Kent WalkerPresident, Global Affairs, CLO
SellAlphabet
Sell
Alphabet
GOOG
$1.1M
11,313 sh
$1.1M
Filed 23/01/25
Traded 23/01/23
Vito S. PantilionePresident & CEO
BuyParke Bancorp
Buy
Parke Bancorp
PKBK
$10.4K
500 sh
$10.4K
Filed 23/01/25
Traded 23/01/23
Richard W. BakerDirector
BuyGuaranty Bancshares
Buy
Guaranty Bancshares
GNTY
$10.3K
300 sh
$10.3K
Filed 23/01/25
Traded 22/05/09
Goldman Sachs Group10% Owner
BuyMasterBrand
Buy
MasterBrand
MBC
$854
100 sh
$854
Filed 23/01/25
Traded 23/01/23
Goldman Sachs Group10% Owner
BuyMasterBrand
Buy
MasterBrand
MBC
$206
24 sh
$206
Filed 23/01/25
Traded 23/01/23
Goldman Sachs Group10% Owner
BuyMasterBrand
Buy
MasterBrand
MBC
$2,562
300 sh
$2,562
Filed 23/01/25
Traded 23/01/23
Goldman Sachs Group10% Owner
BuyMasterBrand
Buy
MasterBrand
MBC
$3,894
463 sh
$3,894
Filed 23/01/25
Traded 23/01/23
Goldman Sachs10% Owner
BuyMasterBrand
Buy
MasterBrand
MBC
$206
24 sh
$206
Filed 23/01/25
Traded 23/01/23